Who is sponsoring SUP-ICU?

SUP-ICU is sponsored by Dr. Morten Hylander Møller.

What condition does SUP-ICU study?

SUP-ICU studies Gastrointestinal Bleeding, Stress Ulcers.

What drugs are being tested in SUP-ICU?

Interventions: Pantoprazole, Saline (0.9%).

What is the status of SUP-ICU?

SUP-ICU is currently COMPLETED.

Last reviewed 2022-10-26 · How we verify

Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU)

NCT02467621 Phase 4 COMPLETED Results posted

Stress ulcer prophylaxis (SUP) is standard of care in the intensive care unit (ICU), however the quantity and quality of evidence is low and potential harm has been reported. The aim of the SUP-ICU trial is to asses the overall benefits and harms of SUP with proton pump inhibitor in adult critically ill patients in the ICU.

Details

Lead sponsor	Dr. Morten Hylander Møller
Phase	Phase 4
Status	COMPLETED
Enrolment	3350
Start date	2016-01
Completion	2018-01-21

Conditions

Gastrointestinal Bleeding
Stress Ulcers

Interventions

Pantoprazole
Saline (0.9%)

Primary outcomes

Mortality — 90 days
Landmark mortality 90-days after randomization

Countries

Denmark, Finland, Netherlands, Norway, Switzerland, United Kingdom